Pharmidex Revenue and Competitors

London, UK

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Pharmidex's estimated annual revenue is currently $8M per year.(i)
  • Pharmidex's estimated revenue per employee is $201,000

Employee Data

  • Pharmidex has 40 Employees.(i)
  • Pharmidex grew their employee count by 3% last year.

Pharmidex's People

NameTitleEmail/Phone
1
Head GLP/GCP BioanalysisReveal Email/Phone
2
Head OperationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$58.9M2936%N/AN/A
#2
$21.1M1055%N/AN/A
#3
$113.4M5641%N/AN/A
#4
$20.9M104-5%N/AN/A
#5
$37M1849%N/AN/A
#6
$45.4M226-24%N/AN/A
#7
$16.1MN/AN/AN/A
#8
$69.7M3470%N/AN/A
#9
$8M403%N/AN/A
#10
$25.5M12728%N/AN/A
Add Company

What Is Pharmidex?

Pharmidex provides translational solutions using its world renowned expertise in CNS/Oncology, drug discovery and ADMET/PK. Founded in the UK in 2002, Pharmidex operates in state-of-the-art facilities in London and Hatfield to provide high quality bespoke experimental data to support drug discovery & development. The industry expertise within Pharmidex and its dynamic client interaction delivers a high level of customer satisfaction and has been the key in forming strategic international alliances. Key areas of expertise are: in-vitro & in-life ADMET, Pharmacology, CNS/Oncology, Drug Discovery, Bioanalysis, Metabolite Identification, Bioimaging and toxicology. Pharmidex has a global list of clients that includes major Pharma, biotechs, governmental institutes, universities and medical charities. We have experience working with clients based in North America, Europe and Japan as well as other territories. Pharmidex has also extensive experience and success in grant funded research collaborations.

keywords:N/A

N/A

Total Funding

40

Number of Employees

$8M

Revenue (est)

3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Pharmidex News

2018-11-12 - This UK Biotech Wants to Make Antibodies Easy to Swallow

To get there, Intract is working as part of an industrial collaboration, including UK companies Pharmidex, Quay Pharma and the Center for ...

2017-10-20 - Innovate UK award BioMoti, Pharmidex and Queen Mary ...

BioMoti (London, UK), Pharmidex (London, UK) and Queen Mary University of London (London, UK) have been awarded a grant of £662,222 ...

2017-10-16 - BioMoti and CRO partner Pharmidex receive grant to advance ...

BioMoti and Pharmidex have received funding to advance proof-of-concept precision medicine studies – which if successful, could help secure ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.7M4038%$4.3M
#2
N/A400%N/A
#3
$4.6M40-26%N/A
#4
$4.8M400%N/A
#5
$3.3M40-18%N/A